aiqbench analysis
CLARITY introduces a generative world model capable of simulating counterfactual disease trajectories under various treatment conditions, addressing the limitations of static predictors in oncology. By integrating imaging data with longitudinal clinical context, it enables closed-loop planning that iteratively refines therapy proposals based on long-term survival outcomes. This approach represents a significant step forward for AI-driven decision support systems where modeling complex physiological dynamics over time is critical.
CLARITY: Medical World Model for Guiding Treatment Decisions by Simulating Context-Aware Disease Trajectories
arXiv:2512.08029v4 Announce Type: replace Abstract: Clinical decision-making in oncology requires forecasting how disease evolves under treatment, yet most AI systems remain static predictors that cannot model longitudinal, treatment-conditioned progression. Although generative and world models have demonstrated strong capabilities in general domains, their adaptation to medicine remains limited and insufficient for capturing complex, treatment-induced physiological dynamics across temporal scales. To address these gaps, we introduce CLARITY, a medical world model that enables counterfactual simulation of treatment-conditioned disease trajectories for clinical decision-making. By jointly encoding imaging-derived latent states, temporal intervals that capture irregular follow-ups, and patient-specific clinical context, CLARITY learns smooth and interpretable representations of disease progression, allowing the model to simulate how alternative treatments reshape future disease dynamics. Because treatment optimization is inherently sequential and uncertain, requiring evaluation of long-term outcomes across multiple possible interventions, we further propose an entropy-regularized, computationally efficient long-horizon prediction-to-decision framework that plans treatment strategies over imagined disease trajectories and iteratively refines therapy proposals through survival-aware feedback, forming a closed-loop simulation-to-decision framework for treatment planning. CLARITY achieves state-of-the-art performance in treatment planning and survival prediction across three cancer datasets, including two brain tumor cohorts (MU-Glioma-Post and zero-shot on UCSF-ALPTDG) and one breast cancer dataset (ISPY-2), demonstrating strong generalization across cancer types while consistently outperforming prior generative methods and medical-domain large language model baselines.
Abstract:Clinical decision-making in oncology requires forecasting how disease evolves under treatment, yet most AI systems remain static predictors that cannot model longitudinal, treatment-conditioned progression. Although generative and world models have demonstrated strong capabilities in general domains, their adaptation to medicine remains limited and insufficient for capturing complex, treatment-induced physiological dynamics across temporal scales. To address these gaps, we introduce CLARITY, a medical world model that enables counterfactual simulation of treatment-conditioned disease trajectories for clinical decision-making. By jointly encoding imaging-derived latent states, temporal intervals that capture irregular follow-ups, and patient-specific clinical context, CLARITY learns smooth and interpretable representations of disease progression, allowing the model to simulate how alternative treatments reshape future disease dynamics. Because treatment optimization is inherently sequential and uncertain, requiring evaluation of long-term outcomes across multiple possible interventions, we further propose an entropy-regularized, computationally efficient long-horizon prediction-to-decision framework that plans treatment strategies over imagined disease trajectories and iteratively refines therapy proposals through survival-aware feedback, forming a closed-loop simulation-to-decision framework for treatment planning. CLARITY achieves state-of-the-art performance in treatment planning and survival prediction across three cancer datasets, including two brain tumor cohorts (MU-Glioma-Post and zero-shot on UCSF-ALPTDG) and one breast cancer dataset (ISPY-2), demonstrating strong generalization across cancer types while consistently outperforming prior generative methods and medical-domain large language model baselines.
Machine Learning (cs.LG); Computer Vision and Pattern Recognition (cs.CV)
arXiv:2512.08029 [cs.LG]
(or arXiv:2512.08029v4 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2512.08029 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 309 words
Related coverage
Medical world models: representing medical states, modelling clinical dynamics and guiding intervention policies
arXiv · Jun 16, 2026

MedPAIR: Measuring Whether Physicians and AI Agree on What Matters in Medical QA
Snorkel AI Blog · Oct 2, 2026
The Continual Constitutional Convention: How language models revise the documents that govern them
AI Alignment Forum · Oct 13, 2026
Enabling a new model for healthcare with AI co-clinician
Google DeepMind · Apr 30, 2026